RxDoctor Payments Data

John Terpstra, DO

Emergency Medicine · Dayton, OHNPI 1528171030

Payments from drug & device makers

What this record shows

This record is dominated by charitable contributions: $7,500 of the $7,753 with a category attached, or 96.7%. Midmark Corporation accounts for 96.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $7,500 and has fallen 97.6% since, to $177 in 2024. Among emergency medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,753in general payments, 2019–2025

Across 12 payments — averaging $646.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Midmark Corporation$8K
  • AstraZeneca$85
  • United Therapeutics Corporation$49
  • Lilly USA, LLC$31
  • Otsuka America Pharmaceutical, Inc.$22
  • Abbott$21
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$2533%
  • Charitable contribution$7,50097%

General payments by program year

21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,753 in reported general payments places this provider in the 95th percentile of 2,431 emergency medicine providers in Ohio.

See all emergency medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$51,889
Medicare patients
287
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$39,155
MounjaroTirzepatide22$33,187
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$12,948
EliquisApixaban16$10,658
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$5,663
Albuterol Sulfate HfaAlbuterol Sulfate41$1,210
Atorvastatin Calcium95$570
Rosuvastatin Calcium33$514
Metoprolol Succinate28$349
Levothyroxine Sodium51$341
Tamsulosin Hcl27$326
Gabapentin22$322
Alprazolam24$319
Famotidine26$288
Pantoprazole Sodium23$275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$39,15542 claims
Lilly USA, LLCMounjaro$31$33,18722 claims
AstraZenecaBreztri Aerosphere$85$12,94821 claims
PfizerEliquis$16$10,65816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,431 emergency medicine providers in Ohio.

Other emergency medicine in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →